Istituto di Ricerca in Biomedicina
Ticino is becoming a biotech hub Greater Zurich Area April 1, 2021 Ricerca biomedica senza frontiere Ticino Management April, 2021 Immunoncologia, alleanza vincente Ticino Management May, 2021 Schierati con il
L’avvicendamento ai vertici dell’Istituto di ricerca in biomedicina (IRB, affiliato all’USI) è avvenuto alla fine di luglio: il Prof. Antonio Lanzavecchia passa il testimone al Prof. Davide Robbiani, di ritorno
on April 3, 2020 When DNA breaks, cells need to join the broken DNA pieces in an accurate way to prevent mutations. Cells utilize the so-called homologous recombination pathway to
Lunedì, 16 Marzo, 2020 Un gruppo di ricercatori dell’Istituto di Ricerca in Biomedicina (IRB) di Bellinzona, Università della Svizzera italiana, e dell’Istituto Europeo di Oncologia (IEO) di Milano ha identificato
Date: 12/05/2022 12:00 pm Speaker: Prof. Dr. Carola G. Vinuesa Seminar: Regulation of B cell responses From: Francis Crick Institute in London (GB) PhD Program Coordinator: Silvia Monticelli Date: 12.05.2022 12:00
Niccolò Bianchi successfully defended his PhD thesis, which was presented at the University of Bern on December 16th, 2021. His thesis title was “Regulation of inflammatory phenotypes in human T
Giordano Reginato successfully defended his PhD thesis, which was presented at ETH on October 26th, 2021. His thesis title was “Understanding the function of the MRE11 complex in homologous recombination”
On January 18, 2022, Josipa Jerak (Cellular Immunology Lab), Gaia Antonini (Systems Immunology Lab) and Pedro Ventura (Immune Mechanisms Lab) were announced as the grantees of the ninth IRB PhD
L’IRB comunica che ogni comunicato stampa menzionando l’IRB dovrebbe essere rivisto dal nostro servizio di media e comunicazione. Contatti:
Andrea Nava
andrea.nava@irb.usi.ch
+41 58 666 7250
Facebook / Twitter
